MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,341,000 | +73.9% | 19,200 | +67.1% | 0.01% | +57.1% |
| Q2 2022 | $771,000 | +262.0% | 11,491 | +343.5% | 0.01% | +250.0% |
| Q1 2022 | $213,000 | -1.4% | 2,591 | +43.4% | 0.00% | 0.0% |
| Q4 2021 | $216,000 | -39.5% | 1,807 | -10.4% | 0.00% | 0.0% |
| Q3 2021 | $357,000 | +11.9% | 2,017 | +2.3% | 0.00% | 0.0% |
| Q2 2021 | $319,000 | -43.9% | 1,972 | -40.6% | 0.00% | -50.0% |
| Q1 2021 | $569,000 | -22.1% | 3,322 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $730,000 | +266.8% | 3,322 | +176.8% | 0.01% | +150.0% |
| Q3 2020 | $199,000 | +485.3% | 1,200 | +300.0% | 0.00% | – |
| Q2 2020 | $34,000 | +100.0% | 300 | +36.4% | 0.00% | – |
| Q1 2020 | $17,000 | -51.4% | 220 | -18.5% | 0.00% | – |
| Q4 2019 | $35,000 | +191.7% | 270 | +80.0% | 0.00% | – |
| Q3 2019 | $12,000 | -20.0% | 150 | 0.0% | 0.00% | – |
| Q2 2019 | $15,000 | +36.4% | 150 | 0.0% | 0.00% | – |
| Q1 2019 | $11,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |